The 8th Habit: From Effectiveness to Greatness Parent Effectiveness Training : The Proven Program for Raising Responsible Children Leader Effectiveness Training L.E.T.: The Proven People Skills for Today's Leaders Tomorrow Leadership and the One Minute Manager : Increasing Effectiveness Through Situational Leadership Don't Oil the Squeaky Wheel: And 19 Other Contrarian Ways to Improve Your Leadership Effectiveness Performance Management: Changing Behavior that Drives Organizational Effectiveness Competing by Design: The Power of Organizational Architecture Virtual Teams That Work: Creating Conditions for Virtual Team Effectiveness Cost-Effectiveness in Health and Medicine

• Clinical Effectiveness and Evaluation Unit.
• The main aim of the Clinical Effectiveness and Evaluation Unit (CEEU) is to improve the quality of care delivered to patients in the National Health Service. ...
• The Clinical Effectiveness Forum .
• Clinical Effectiveness and Evaluation Unit.

• Cost-effectiveness of Treatment for Chronic Hepatitis C Infection in an Evolving Patient Population .
• Objective  To examine the clinical benefits and cost-effectiveness of newer treatments for chronic hepatitis C infection in a population of asymptomatic, HCV sero-positive but otherwise healthy individuals. ...
• Design and Setting  Cost-effectiveness analysis using a Markov model of the natural history of HCV infection and impact of treatment. ...
• Main Outcome Measures  Lifetime costs, life expectancy, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios. ...
• The incremental cost-effectiveness of combination therapy with pegylated interferon for men ranged from $26 000 to $64 000 per QALY for genotype 1 and from $10 000 to $28 000 per QALY for other genotypes; and for women ranged from $32 000 to $90 000 for genotype 1 and from $12 000 to $42 000 for other genotypes. Because the benefits of treatment were realized largely in the form of improvements in health-related quality of life, rather than prolonged survivorship, cost-effectiveness ratios expressed as dollars per year of life were substantially higher. ...
• Taking account of future technology in cost effectiveness analysis.
• Cost-effectiveness of Treatment for Chronic Hepatitis C Infection.
• Cost-effectiveness of Treatment for Chronic Hepatitis C Infection.

•  Assessments to Maximize Individual, Team and Organizational Effectiveness, Including Selection and Placement for Key Positions.
• Effectiveness, Inc.
• Welcome to The Effectiveness Connection Resource Center, the ultimate resource  for leaders who want to discover and develop top talent to maximize their  competitive advantage, and for  the practitioners who serve them. ...
• Email bob@effectiveness. com to obtain a complementary “Focusing Your Priorities” workshop and phone consultation from Bob Moore, The Effectiveness Coach® and Master Facilitator.
• The Effectiveness Connection resources include assessments, complete learning systems and programs for in-house implementation along with best practices blended learning systems with an evaluation process to assure return on learning expectations. ...
• Assessing Personal Effectiveness.
• Assessing Team Effectiveness.
• Identify the key areas that determine team effectiveness and establish a benchmark to measure increases in team effectiveness. ...
• Assessing Organizational Effectiveness.
• Assessing Leadership and Management Effectiveness.

• The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease.
• The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease .
• We estimated the clinical benefits and cost effectiveness of three-drug antiretroviral regimens. ...
• Outcome measures included life expectancy, life expectancy adjusted for the quality of life, lifetime direct medical costs, and cost effectiveness in dollars per quality-adjusted year of life gained. ...
• On the basis of additional data from other major studies, the cost-effectiveness ratio for three-drug therapy ranged from $13,000 to $23,000 per quality-adjusted year of life gained. The initial CD4 cell count and drug costs were the most important determinants of costs, clinical benefits, and cost effectiveness. ...
• Expanded Screening for HIV in the United States -- An Analysis of Cost-Effectiveness. ...
• Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy. ...
• Human Immunodeficiency Virus Retesting During Pregnancy: Costs and Effectiveness in Preventing Perinatal Transmission. ...
• Chapter 15: Public Health Policy and Cost-Effectiveness Analysis. ...
• Treatment for Hepatitis C Virus in Human Immunodeficiency Virus-Infected Patients: Clinical Benefits and Cost-effectiveness. ...
• Cost-effectiveness Implications of the Timing of Antiretroviral Therapy in HIV-Infected Adults. ...
• Cost effectiveness analysis in health care: contraindications. ...
• Cost-Effectiveness of HIV Care. ...
• The Cost Effectiveness of Antiretroviral Therapy for HIV Disease. ...

• Effectiveness and Outcomes in Health Care: Proceedings of an Invitational Conference (1990).

• Institutional Effectiveness .

• Learn a set of principles and personal management skills that will change how you view your life and enable you to grow in personal confidence and effectiveness .

• Reading Materials The Unreasonable Effectiveness of Mathematics in the Natural Sciences.

• Individuals wishing to enhance their professional and personal effectiveness through increased self awareness and strategic thinking. ...
• Saddle Sojourns offers flexible-design workshops tailored to meet the specific needs, objectives and focus of each client group in the areas of leadership development, team building and personal effectiveness. ...

• Screening for Type 2 Diabetes Mellitus: A Cost-Effectiveness Analysis .
• In the absence of direct evidence, cost-effectiveness models may provide guidance about preferred screening strategies. ...
• Objective: To estimate the incremental cost-effectiveness of 2 diabetes screening strategies: screening targeted to people with hypertension and universal screening. ...
• Results of Base-Case Analysis: At all ages, incremental cost-effectiveness ratios were more favorable for screening targeted to people with hypertension than for universal screening. ...
• Results of Sensitivity Analysis: In single-way and probabilistic sensitivity analyses, findings were robust to therapy costs, screening costs, screening lead time, reduced effectiveness of intensive antihypertensive therapy, and increased relative risk reduction for stroke attributable to intensive hypertension control. ...
• The cost-effectiveness of targeting diabetes screening to hypertensive adults older than 55 years of age is similar to the cost-effectiveness of many accepted health care interventions. ...
• Development of the cost-effectiveness model was supported by the Centers for Disease Control and Prevention contract 200-97-0621. ...
• The Cost-Effectiveness of Screening for Type 2 Diabetes Annals 2004 140: I-29. ...

• Clinical Effectiveness Support Unit (CESU) was originally set up in 1996, with an all-Wales remit to support the Welsh Office Clinical Effectiveness Initiative. ...

• Cost effectiveness analysis in health care: contraindications .
• In economic evaluation of healthcare interventions, the dominant practice is to calculate an incremental cost effectiveness ratio, usually based on the comparison of a new intervention against current practice. ...
• 2-4 Among the reasons given for this are that opportunities for reducing costs while maintaining quality still arise, and that cost effectiveness analyses do not take all factors into account. ...
• Achieving the same result more cheaplya success for economicsrepresents a classic cost effectiveness approach. ... We contend that, beyond the classic approach, many studies labelled as cost effectiveness analyses of health care are not really that at all. ... Thus, there are contraindications to the use of cost effectiveness analysis in health care, and an alternative economic approach is required. ...
• Then we make the case that lack of adherence to such principles, through current practice of reducing everything to incremental cost effectiveness ratios, leads to contraindications. ...
• The theoretical basis of the use of incremental cost effectiveness ratios needs re-examination These ratios have little to do with cost effectiveness, as they often imply a need for more resources, thus raising questions of broader resource allocation Lack of recognition of this allocation aspect is likely to lead to disappointment with economic evaluation generally Authors making economic evaluations should pay more attention to the type of efficiency question being considered and its implications for opportunity cost; they should not make recommendations if resource allocation issues are involved Guidelines for economic evaluations should be revised to take account of concepts of efficiency .
• By deriving estimates of the costs and the effectiveness of a new procedure, and relating them to the status quo, it should be possible to determine whether the procedure is less costly and at least as effective as the status quo, in which case it would be judged to be better (more technically efficient); or more costly and more effective, in which case a judgment has to be made about whether the extra cost is worth the gains achieved (a question of allocative efficiencyif the number of patients treated remains the same, more resources would have to be allocated to this area of care at the expense of another group of patients).
• Our main point is that cost effectiveness analysis alone cannot handle questions of allocative efficiency, although it is currently being asked to do so, but there are economic evaluation approaches that can. Data on effectiveness and cost can be brought together in a matrix, combining potential impacts on effectiveness and cost resulting from a change in care (figure). The optimum position is cell A1; costs are saved and greater effectiveness achieved relative to existing care. ... In C1, a judgment is required as to whether the more costly new procedure is worthwhile in terms of additional effectiveness (the allocative efficiency question). ... Cell C1 is where alteplase falls, along with the results of many other "cost effectiveness analyses. ...
• Effectiveness-cost matrix for comparison of new treatment with current care .
• Contraindications to cost effectiveness analysis .

Do you have a great site about Effectiveness? Is your Effectiveness site listed here? Would you like a prefered placement of your site in this directory?

It's easy! First place, the HTML from the box below on your page that you would like listed in this directory.

Then use our link submission request with your name, your contact information, and the URL of your site that has a link to this directory. After we verify your link to us, we'll make sure your site stays in our directory, and we'll give it prefered placement here also.

Here is how to make a simple text link to us. Just copy the code in this box to your website:

We can also develop a custom Guide To The Internet for your site. Please request your own custom Guide To The Internet.